(Q54812494)

English

CHLA-258

cell line

CHLA258

In more languages

default for all languages

No label defined

No description defined

Statements

1 reference

Cellosaurus release 49

13 July 2024

cancer cell line

1 reference

Cellosaurus release 49

13 July 2024

described by source

Fenretinide cytotoxicity for Ewing's sarcoma and primitive neuroectodermal tumor cell lines is decreased by hypoxia and synergistically enhanced by ceramide modulators

1 reference

Cellosaurus release 49

13 July 2024

National Cancer Institute pediatric preclinical testing program: model description for in vitro cytotoxicity testing

1 reference

Cellosaurus release 49

13 July 2024

Characterization and drug resistance patterns of Ewing's sarcoma family tumor cell lines

1 reference

Cellosaurus release 49

13 July 2024

The genomic landscape of the Ewing Sarcoma family of tumors reveals recurrent STAG2 mutation

1 reference

Cellosaurus release 49

13 July 2024

Sarcoma Cell Line Screen of Oncology Drugs and Investigational Agents Identifies Patterns Associated with Gene and microRNA Expression

1 reference

Cellosaurus release 49

13 July 2024

Characterization of Human Cancer Cell Lines by Reverse-phase Protein Arrays

1 reference

Cellosaurus release 49

13 July 2024

established from medical condition

medulloblastoma

1 reference

Cellosaurus release 36

20 November 2020

derived from organism type

1 reference

Cellosaurus release 49

13 July 2024

Identifiers

1 reference

Cellosaurus release 49

13 July 2024

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54812494&oldid=2258114714"